Near-InfraRed PhotoImmunoTherapy (NIR-PIT) for the local control of solid cancers: Challenges and potentials for human applications
- PMID: 33836238
- PMCID: PMC8177002
- DOI: 10.1016/j.critrevonc.2021.103325
Near-InfraRed PhotoImmunoTherapy (NIR-PIT) for the local control of solid cancers: Challenges and potentials for human applications
Abstract
Near-InfraRed PhotoImmunoTherapy (NIR-PIT) is a novel cancer-targeted treatment effected by a chemical conjugation between a photosensitiser (e.g. the NIR phthalocyanine dye IRDye700DX) and a cancer-targeting moiety (e.g. a monoclonal antibody, moAb). Delivery of a conjugate in vivo leads to accumulation at the tumour cell surface by binding to cell surface receptors or antigens. Upon deployment of focal NIR-light, irradiation of the conjugate results in a rapid, targeted cell death. However, the mechanisms of action to produce the cytotoxic effects have yet to be fully understood. Herein, we bring together the current knowledge of NIR-PIT from preclinical and clinical studies in a variety of cancers highlighting the key unanswered research questions. Furthermore, we discuss how to enhance the local control of solid cancers using this novel treatment regimen.
Keywords: Clinical trials; In vitro; In vivo; Local control; Monoclonal antibodies; Near-InfraRed fluorophores; PhotoImmunoTherapy; Solid cancers.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Nothing to declare.
Figures
Similar articles
-
Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221145992. doi: 10.1177/15330338221145992. Technol Cancer Res Treat. 2023. PMID: 36734039 Free PMC article. Review.
-
Near-Infrared Photoimmunotherapy of Cancer.Acc Chem Res. 2019 Aug 20;52(8):2332-2339. doi: 10.1021/acs.accounts.9b00273. Epub 2019 Jul 23. Acc Chem Res. 2019. PMID: 31335117 Free PMC article. Review.
-
Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.Oncotarget. 2016 Nov 29;7(48):79408-79416. doi: 10.18632/oncotarget.12710. Oncotarget. 2016. PMID: 27765903 Free PMC article.
-
Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.World J Gastroenterol. 2018 Dec 28;24(48):5491-5504. doi: 10.3748/wjg.v24.i48.5491. World J Gastroenterol. 2018. PMID: 30622378 Free PMC article.
-
Hurdles for the wide implementation of photoimmunotherapy.Immunotherapy. 2021 Dec;13(17):1427-1438. doi: 10.2217/imt-2021-0241. Epub 2021 Oct 25. Immunotherapy. 2021. PMID: 34693721 Review.
Cited by
-
Quickly evolving near-infrared photoimmunotherapy provides multifaceted approach to modern cancer treatment.View (Beijing). 2022 May;3(3):20200110. doi: 10.1002/VIW.20200110. Epub 2021 Aug 27. View (Beijing). 2022. PMID: 37448778 Free PMC article.
-
Synergistic Nanomedicine: Photodynamic, Photothermal and Photoimmune Therapy in Hepatocellular Carcinoma: Fulfilling the Myth of Prometheus?Int J Mol Sci. 2023 May 5;24(9):8308. doi: 10.3390/ijms24098308. Int J Mol Sci. 2023. PMID: 37176014 Free PMC article. Review.
-
Combination of Two Photosensitisers in Anticancer, Antimicrobial and Upconversion Photodynamic Therapy.Pharmaceuticals (Basel). 2023 Apr 19;16(4):613. doi: 10.3390/ph16040613. Pharmaceuticals (Basel). 2023. PMID: 37111370 Free PMC article. Review.
-
Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy.Int J Mol Sci. 2023 Jan 31;24(3):2655. doi: 10.3390/ijms24032655. Int J Mol Sci. 2023. PMID: 36768976 Free PMC article. Review.
-
Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221145992. doi: 10.1177/15330338221145992. Technol Cancer Res Treat. 2023. PMID: 36734039 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
